Ejaculatory disorders are the most common disorders of sexual function in the male. The various ejaculatory disorders include early ejaculation (previously premature ejaculation), delayed/anejaculation, retrograde ejaculation, painful ejaculation, and postorgasmic illness syndrome. The approach to the management of ejaculatory dysfunction is multifaceted, encompassing psychological, pharmacological, surgical, and newer therapies. Psychotherapy, including cognitive behavioural therapy and sex therapy, has proven effective in addressing the underlying psychological factors contributing to ejaculatory dysfunction. In the recent years, despite the significant advancements achieved in medical management of ejaculatory dysfunctions, like selective serotonin reuptake inhibitors, topical sprays, and creams, due to the poor realization of the mechanisms causing these dysfunction, there are no specific medications that can completely reverse the disorders. There are still no FDA-approved medications for the management of these disorders except for early ejaculation. Furthermore, emerging therapies, including selective dorsal neurectomy, glans penis augmentation, etc., offer innovative options for patients who do not respond to conventional treatments. This chapter emphasizes the importance of integrated management strategies for ejaculatory disorders by incorporating algorithms and recent advances. The chapter also aims to offer practical tips in guiding the healthcare professionals for a systematic and customized approach toward management of ejaculatory disorders.